Takayuki Takeichi, Hideaki Okajima, Hiroko Suda, Shintarou Hayashida, Hironori Iwasaki, Manuel Zeledon Ramirez, Mikako Ueno, Katsuhiro Asonuma, Yukihiro Inomata – 23 September 2005 – Congenital absence of the portal vein (CAPV) is a rare malformation of the splanchnic venous system. Although CAPV is usually detected in the pediatric age group, our patient was a 35‐year‐old woman. She had been diagnosed with CAPV in 1996 when she was 27 years old. In 1998, she was placed on hemodialysis due to chronic renal failure.

Carlos Margarit, Alfredo Escartín, Lluis Castells, Víctor Vargas, Elena Allende, Itxarone Bilbao – 23 September 2005 – The best treatment option for patients with single, early hepatocellular carcinoma (HCC) and cirrhosis, good liver function, and absence of portal hypertension remains to be established. The aim of this work was to compare the outcome of liver resection (LR) with that of liver transplantation (LT) for single, early HCC in Child‐Turcotte‐Pugh class A patients with cirrhosis younger than 70 years of age.

23 September 2005

Rajiv Jalan – 23 September 2005

Anthony J. Demetris, John G. Lunz – 23 September 2005

Samer Gawrieh, Bettina G. Papouchado, Lawrence J. Burgart, Shogo Kobayashi, Michael R. Charlton, Gregory J. Gores – 23 September 2005 – Only a subset of hepatitis C virus (HCV)‐infected patients develop progressive hepatic fibrosis after liver transplantation (LT). Hepatic stellate cell (HSC) activation is a pivotal step in hepatic fibrosis and precedes clinically apparent fibrosis. We determined whether early HSC activation, measured in 4‐month protocol post‐LT biopsies, is predictive of subsequent development of more histologically severe recurrence of HCV.

Thomas Longerich, Christoph Eisenbach, Roland Penzel, Thomas Kremer, Christa Flechtenmacher, Burkhard Helmke, Jens Encke, Thomas Kraus, Peter Schirmacher – 23 September 2005 – Herpes virus hepatitis (HSV) represents a form of acute necrotizing hepatitis, which most frequently develops in immunocompromised patients. Therapeutic options include high‐dose intravenous acyclovir and liver transplantation. We report the first case of recurrent HSV hepatitis after liver retransplantation, which occurred despite continuous administration of high‐dose intravenous antiviral therapy.

Nanne K. H. de Boer, Chris J.J. Mulder, Adriaan A. van Bodegraven – 23 September 2005

Jens G. Brockmann, Christian August, Heiner H. Wolters, Ralf Hömme, Daniel Palmes, Hideo Baba, Hans‐U. Spiegel, Karl H. Dietl – 23 September 2005 – The impact of 3 different reperfusion sequences following orthotopic liver transplantation (OLT) in pigs were evaluated. The reperfusion technique commonly performed is primary portal in order to shorten warm ischemic times (WITs). Experimental and clinical data, usually comparing 2 out of 3 possible reperfusion sequences, provide controversial results.

Chih‐Che Lin, Feng‐Rong Chuang, Chih‐Hsiung Lee, Chih‐Chi Wang, Yaw‐Sen Chen, Yueh‐Wei Liu, Bruno Jawan, Chao‐Long Chen – 23 September 2005 – The purpose of this study is to find out whether basiliximab administration will improve postoperative renal function by delaying the start of tacrolimus and decreasing of dosage requirement for tacrolimus in adult living donor liver transplantation (LDLT). Forty‐five adult LDLT recipients were enrolled in the study.